Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Conditions

• Influenza

Interventions

• BIOLOGICAL: High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)
• BIOLOGICAL: High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 45 μg, (split-virion, inactivated)
• BIOLOGICAL: High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 60 µg (split-virion, inactivated)
• BIOLOGICAL: Fluarix Quadrivalent Influenza vaccine (Unadjuvanted QIV-SD) (Inactivated)
• BIOLOGICAL: FLUAD Pediatric (adjuvanted TIV) (Surface Antigen, Inactivated)

Sponsor

Sanofi Pasteur, a Sanofi Company